A systematic review and meta-analysis evaluates the efficacy and safety of chimeric antigen receptor T-cell therapy in treating primary central nervous system lymphoma. The findings contribute to understanding potential therapeutic options for this rare malignancy.
efficacy and safety of chimeric antigen receptor t cell therapy in primary central nervous system lymphoma a systematic review and meta analysis
Original title: “Efficacy and safety of chimeric antigen receptor T-cell therapy in primary central nervous system lymphoma: a systematic review and meta-analysis.”